The current study protocol points to an innovative research that can contribute to better understand the impact and potential benefits of psychological interventions in
haemophilia care setting.
Psychosocial health and effective pain management are considered essential end points for optimal
haemophilia care, but there is a significant gap in evidence - based treatments targeting these outcomes in people with haemophilia (PWH).
Not exact matches
We have developed leading products within diabetes
care,
haemophilia, growth hormone therapy and hormone replacement therapy.
We really now have the potential to transform
care for people with
haemophilia using a single treatment for people who at the moment must inject themselves as often as every other day.